BMRN vs OSUR · P/E 40, rev $1.76B vs rev $58.6M
Biomarin Pharmaceutical Inc (BMRN) versus OraSure Technologies Inc (OSUR) — a side-by-side from cached financials, not a winner call.
Biomarin Pharmaceutical Inc (BMRN) is a biotechnology company listed on NASDAQ.
OraSure Technologies Inc (OSUR) is a medical instruments & supplies company listed on US.
Latest reported BMRN revenue for 2026-06-30 was $1.76B. Net income was $150.3M. BMRN currently screens at market cap $10.63B and trailing P/E 39.6.
Latest reported OSUR revenue for 2026-06-30 was $58.6M. Net income was -$16.1M. OSUR currently screens at market cap $225.1M.
BMRN currently screens at market cap $10.63B and trailing P/E 39.6. OSUR currently screens at market cap $225.1M.
Not investment advice. Open the BMRN and OSUR stock pages for the full models.
Not investment advice.